![Immune system / Pharmaceuticals policy / Immunosuppressants / Natalizumab / Pharmaceutical Benefits Scheme / Interferon beta-1a / Immunology / Multiple sclerosis / Medicine Immune system / Pharmaceuticals policy / Immunosuppressants / Natalizumab / Pharmaceutical Benefits Scheme / Interferon beta-1a / Immunology / Multiple sclerosis / Medicine](https://www.pdfsearch.io/img/3d564e949d18039a7103cf29812b35ec.jpg)
| Document Date: 2015-03-02 18:33:43 Open Document File Size: 229,87 KBShare Result on Facebook
Country Australia / / MedicalCondition MS / disease / / Organization Department of Health / Streamlined Authority / / Person Matthew Miles / / Position Chief Executive Officer / / Product Tysabri / Avonex / / ProvinceOrState Mississippi / /
SocialTag |